Mallika Datta, Sarah Abouassali, Shreya Raman, Christian Blue, Robert Marcaccini, Paschalia Mountziaris, Xiaoyan Deng, Dipankar Bandyopadhyay, Kandace P McGuire
{"title":"The Relationship Between Radiation History and Outcomes of Immediate Implant-Based Breast Reconstruction.","authors":"Mallika Datta, Sarah Abouassali, Shreya Raman, Christian Blue, Robert Marcaccini, Paschalia Mountziaris, Xiaoyan Deng, Dipankar Bandyopadhyay, Kandace P McGuire","doi":"10.1016/j.clbc.2025.04.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Postmastectomy Radiotherapy (PMRT) has become standard of care for patients with breast cancer. However, local recurrence following breast conserving therapy is increasing in incidence due to increased survivorship. The relationship between prior radiation therapy, PMRT and immediate breast reconstruction (IBR) outcomes has not been widely studied. We aim to assess factors that correlate with post-IBR complications in the face of radiation therapy.</p><p><strong>Methods: </strong>An IRB approved retrospective cohort review of 262 patients was completed using our tumor registry to identify female patients age ≥ 18 with and without history of radiation who underwent mastectomy with IBR. Operative, clinical, and pathological data was collected, and univariate and multiple logistic regression analyses were conducted to evaluate the relationship between receipt of radiation and major and minor complications. Kaplan-Meier analysis was also conducted to assess the differences between the time to receipt of radiation and cancer recurrence amongst the 3 treatment groups.</p><p><strong>Results: </strong>There was no correlation between major or minor complications and a history of prior radiation. Patients with PMRT demonstrated a higher incidence of \"other\" minor complications (OR 2.8, CI 1.27-6.28, P = .01), such as erythema and edema. There was a higher incidence of implant exposure requiring reoperation (OR 5.7, CI 1.36-23.78, P = .01) and \"other'' minor complications (OR 3.1, CI 1.32-7.35, P < .001) in patients with PMRT. Receipt of PMRT was associated with lower survival in compared to patients with no history of radiation treatment.</p><p><strong>Conclusion: </strong>Our study found no significant associations between history of prior radiation and surgical complications after mastectomy and IBR. However, patients with PMRT were at increased risk of developing minor complications requiring reoperation. This suggests that we should discuss radiation concerns preoperatively and manage expectations regarding its effect on outcome.</p>","PeriodicalId":10197,"journal":{"name":"Clinical breast cancer","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical breast cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clbc.2025.04.005","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Postmastectomy Radiotherapy (PMRT) has become standard of care for patients with breast cancer. However, local recurrence following breast conserving therapy is increasing in incidence due to increased survivorship. The relationship between prior radiation therapy, PMRT and immediate breast reconstruction (IBR) outcomes has not been widely studied. We aim to assess factors that correlate with post-IBR complications in the face of radiation therapy.
Methods: An IRB approved retrospective cohort review of 262 patients was completed using our tumor registry to identify female patients age ≥ 18 with and without history of radiation who underwent mastectomy with IBR. Operative, clinical, and pathological data was collected, and univariate and multiple logistic regression analyses were conducted to evaluate the relationship between receipt of radiation and major and minor complications. Kaplan-Meier analysis was also conducted to assess the differences between the time to receipt of radiation and cancer recurrence amongst the 3 treatment groups.
Results: There was no correlation between major or minor complications and a history of prior radiation. Patients with PMRT demonstrated a higher incidence of "other" minor complications (OR 2.8, CI 1.27-6.28, P = .01), such as erythema and edema. There was a higher incidence of implant exposure requiring reoperation (OR 5.7, CI 1.36-23.78, P = .01) and "other'' minor complications (OR 3.1, CI 1.32-7.35, P < .001) in patients with PMRT. Receipt of PMRT was associated with lower survival in compared to patients with no history of radiation treatment.
Conclusion: Our study found no significant associations between history of prior radiation and surgical complications after mastectomy and IBR. However, patients with PMRT were at increased risk of developing minor complications requiring reoperation. This suggests that we should discuss radiation concerns preoperatively and manage expectations regarding its effect on outcome.
背景:乳房切除术后放射治疗(PMRT)已成为乳腺癌患者的标准治疗方法。然而,保乳治疗后局部复发的发生率随着生存率的增加而增加。既往放射治疗、PMRT和即时乳房重建(IBR)结果之间的关系尚未得到广泛研究。我们的目的是评估放射治疗中与ibr后并发症相关的因素。方法:IRB批准了262例患者的回顾性队列研究,使用我们的肿瘤登记处来确定年龄≥18岁,有或没有放射史的接受乳房切除术IBR的女性患者。收集手术、临床和病理资料,进行单因素和多因素logistic回归分析,评价放疗与主要和次要并发症的关系。还进行了Kaplan-Meier分析,以评估三个治疗组接受放射治疗的时间和癌症复发率之间的差异。结果:主要或次要并发症与既往放疗史无关。PMRT患者的“其他”轻微并发症发生率更高(OR 2.8, CI 1.27-6.28, P = 0.01),如红斑和水肿。PMRT患者有较高的再手术种植体暴露发生率(OR 5.7, CI 1.36-23.78, P = 0.01)和“其他”轻微并发症发生率(OR 3.1, CI 1.32-7.35, P < 0.001)。与没有放射治疗史的患者相比,接受PMRT与较低的生存率相关。结论:我们的研究发现既往放疗史与乳房切除术后手术并发症和IBR之间没有显著关联。然而,PMRT患者发生需要再手术的轻微并发症的风险增加。这表明我们应该在手术前讨论辐射问题,并管理其对预后影响的预期。
期刊介绍:
Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.